add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Tired of Waiting, Teva AdvancesMotley Fool - - 1 hour ago Teva doesn't mention having tested XM02 in acute myeloid leukemia or severe chronic neutropenia, both of which are approved indications for Neupogen, ... New Data on Bristol-Myers Squibb Oncology Compounds to be Featured in Oral ...Welt Online - 3 hours ago Two oral presentations will feature data on the investigational use of SPRYCEL® (dasatinib) in patients with newly-diagnosed chronic myeloid leukemia (CML) ... Sunesis To REVEAL New Data On Lead Product Candidate At ASH MeetingRTT News - 8 hours ago The company is evaluating Voreloxin in clinical trials of AML (acute myeloid leukemia) and platinum-resistant ovarian cancer. ... The day I thought I was dyingThe Australian - - 8 hours ago A decade ago he was diagnosed with acute myeloid leukemia. In July, after a misdiagnosis by an American doctor, he was forced to stare it down again. ... Wild wind's a pain, but Lyle's learnt the hard way about life's challengesSydney Morning Herald - - 8 hours ago In 1999, acute myeloid leukaemia had him stuck in bed for nine months while he had chemotherapy. He needed another year to rediscover the energy to walk a ... University of Texas MD Anderson Cancer Center and Stemline Therapeutics enter ...News-Medical.net - 10 hours ago As part of this collaboration, MD Anderson has joined an ongoing Phase I/II clinical trial of SL-401 in patients with acute myeloid leukemia (AML) and ... ASH meeting to showcase Novartis portfolioPharmacy Europe - 11 hours ago ... Philadelphia chromosome-positive chronic myeloid leukemia (Ph+CML) in chronic phase (Abstract #LBA-1; Tuesday, December 8, 2009 at 7:30 AM CST). ... Fighting a Smarter War on CancerThe News Journal - 13 hours ago After a long pause, someone invariably will say “Gleevec,” a pill that treats a terrible disease called chronic myeloid leukemia. Gleevec, a brand name for ... Significant potential of late- and mid-stage Novartis hematology portfolio to ...PR Newswire (press release) - 15 hours ago ... 200 mg capsules in a form of chronic myeloid leukemia, demonstrate the strength of the company's hematology portfolio in advancing the care of patients. ... Significant potential of late- and mid-stage Novartis hematology portfolio to ...PR-inside.com (press release) - 15 hours ago ... Late-breaking abstract to report data from pivotal trial of Tasigna® versus Glivec® in newly diagnosed patients with a form of chronic myeloid leukemia ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
